DengYue Medicine (DengYueMed/Hong Kong Dengyue Pharmaceutical Limited), founded in 2019, is located in Hong Kong SAR. DengYue is licensed by the Department of Health of Hong Kong to take photos of pharmaceutical import and export wholesalers, specializing in the import and export of new and specialty drugs as well as isolated drugs in the field of major chronic diseases.
- 4 Posts
- 1 Photos
- 0 Videos
- Lives in Hong Kong
- From 6/F, Tai Tak Industrial Building, New Territories
- Other
- 08/01/2005
- Followed by 0 people
Recent Updates
- Explorando os Efeitos em Cascata da Operação Selada de Hainan nas Exportações Farmacêuticas da ChinaNo panorama em constante evolução do comércio global, o setor farmacêutico da China está posicionado para transformações significativas, particularmente com recentes mudanças de política em regiões chave. Ao mergulharmos nas implicações da "operação selada" de Hainan – um movimento que...0 Comments 0 Shares 287 Views 0 ReviewsPlease log in to like, share and comment!
- China's Innovative Drug Export: Accelerating a New Era of GlobalizationIn the rapidly evolving pharmaceutical landscape of 2025, Chinese innovative drug companies are not just participating but leading on the international stage with remarkable speed and ambition. This surge is driven by a combination of technological advancements, supportive government policies, and strategic global partnerships. Over the past 24 hours alone, several pivotal developments have...0 Comments 0 Shares 505 Views 0 Reviews
- Ionis Launches Tryngolza™ (Olezarsen) for FCS With Positive Phase 3 Data and $595,000 Annual List PriceIonis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced the official U.S. launch of Tryngolza™ (olezarsen), a novel, once-monthly RNA-targeted therapy for familial chylomicronemia syndrome (FCS). The drug enters the market at an annual list price of $595,000, following its FDA approval in December 2024. First FDA-Approved Olezarsen Therapy for...0 Comments 0 Shares 2220 Views 0 Reviews
- 0 Comments 0 Shares 829 Views 0 Reviews
More Stories